Binay Shah: The High Cost of Federal Cuts to Cancer Research
Binay Shah, Co-Founder, President, and CEO of Binaytara, shared a post on X:
“Proud to co-author an op-ed with David Aboulafia in The Seattle Times on the devastating impact of proposed federal cuts to cancer research funding.
Washington is home to world-leading institutions like Fred Hutch Cancer Center and University of Washington, driving discoveries that save lives far beyond our state. These cuts would stall clinical trials, cost jobs, and slow progress against cancer at a time when patients need hope the most.
Now is the time to stand together. Please read, share, and make your voice heard.”
Title: Lifesaving cancer research in WA will crater if funding cuts go through
Authors: David Aboulafia, Binay Shah
Read the op-ed:
More posts featuring Binay Shah on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023